Press Releases from CONCEPT HEIDELBERG GmbH (4 total)
Concept Heidelberg takes over MediaVision's GMP eLearning Area
With effect from 1st October 2011, Concept Heidelberg GmbH is taking over the GMP eLearning area of MediaVision BV in Laren, Holland.
MediaVision's interactive GMP eLearning programme is used by more than 300 pharmaceutical companies in over 30 countries. Concept Heidelberg acquires the worldwide rights - MediaVision will still serve customers in Holland and Belgium.
Bert Harenberg, Managing Director of MediaVision, is pleased about the partnership with Concept Heidelberg, an international leading…
The University of Heidelberg invites to The Heidelberg PAT Conference 2007
Practical experience with Near Infrared Spectroscopy (NIR) as the preferred measurement tool in early stages of Process Analytical Technology (PAT) has raised some interesting and pertinent questions. As a direct result there is an increasing interest and growing demand for PAT tools and applications. Multivariate spectroscopic techniques such as NIR, IR, Raman and Terahertz are versatile options to address open issues.
The University of Heidelberg invites to The PAT Conference 2007…
Latest GMP Requirements in Good Transportation Management
Globalisation, counterfeiting problems and the expectations regarding pharmaceutical transport activities and cold chain management are forcing the pharmaceutical industry to challenge their current practices. Companies have to increase their effort and validation activities as one prerequisite for safe and secure transportation of their medical products over boarders and through various climatic conditions. New technologies like RFID are evaluated and implemented.
Authorities like FDA, WHO, USP and PDA are already leading the…
10th APIC/CEFIC European Conference on Active Pharmaceutical Ingredients
In a rapidly changing legislative environment API manufacturers as well as manufacturing authorisation holders are facing global challenges regarding GMP and regulatory compliance.
We have invited speakers from EU, FDA, EMEA, EDQM and national authorities who will present updates on their recent and upcoming activities.
A special feature of the joint day will be 8 highly interactive parallel sessions on specific GMP and Regulatory Affairs topics. Participants have the opportunity to choose…
